Még nem keres résztvevőt itt: Egyesült ÁllamokFázis nélkül
Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety
A legfontosabb adatok
- Ki végzi
- Deliberate Solutions Inc.
- Hol
- Houston (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 650 fő, tervezett
- Kezdés
- 2027. márc. 1.
- Várható befejezés
- 2029. aug. 28.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2025. december 12.
Ki vehet részt
- Életkor
- 18 év – 65 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 16 feltétel megnézéseKevesebb
Ki vehet részt
- English fluency
- 18 to 65 years of age
- Diagnosed with MDD or MDE (Includes Remission, HAM-D <= 7)
- Starting, or has started, a new treatment for depression or anxiety within 2-3 weeks of enrollment
- Access to a laptop or other computer with a well functioning microphone and webcam, and a stable Internet connection
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Resides in the United States at the time of consent and during completion of study
Ki nem vehet részt
- Concurrent medication/treatment:; Receiving any fast-acting treatment for depression or anxiety (e.g. ketamine, psychedelics, deep brain stimulation, etc.) in between initial baseline assessment (A1) and Restest (A2) , or in between Follow up assessment (B1) and Retest (B2); Anxiolytics: Use of benzodiazepines or other anxiety-reducing medications that could affect speech or motor activity, within the past 4 weeks; Antipsychotics and Mood Stabilizers: Medications that can alter cognitive and motor functions, within the past 6 weeks; Stimulants: Use of medications like methylphenidate or amphetamines that affect energy levels and behavior, within the past 2 weeks; Epilepsy medication: seizure activity or medication side effects that may alter behavior, within the past 4 weeks
- Participants who have previously participated in another research project by Deliberate
- Any cognitive impairment that limits ability to provide informed consent or authorization
- Impairment that would prevent participants from completing an online survey and/or engaging in clinician assessment interviews (e.g., visual impairment, motor impairment, hearing impairment)
- Any history or evidence of any of the following conditions:; Neurodevelopmental, Neurocognitive, Neurodegenerative or movement disorders including, but not limited to:; Tourette's syndrome; Multiple Sclerosis; Amyotrophic Lateral Sclerosis; Parkinson's Disease; Stroke; Traumatic Brain Injury; Facial paralysis
- Conditions with vocal cord impact:; Vocal cord injury or cerebrovascular accident or head trauma with residual dysarthria in the past year; Disorders that may impact vocal cords such as acute or chronic laryngitis, vocal cord paresis or paralysis, or spasmodic dysphonia; Past or active heavy smokers (an average of >20 cigarettes per day)
- Schizophrenia Spectrum and Other Psychotic Disorders:; Individuals with a current or past diagnosis of Schizophrenia, Schizoaffective Disorder, or other psychotic disorders, including Delusional Disorder and Brief Psychotic Disorder; Current hypomanic episode as defined by DSM-5 criteria. This includes those with Bipolar I Disorder, Bipolar II Disorder, or Cyclothymic Disorder who are not in a stable mood state at the time of assessment; Chronic Pain Conditions: Such as fibromyalgia, which may affect facial expressions and vocal tone; Prosthetic Facial Devices: Could affect facial recognition algorithms. Cosmetic Procedures: Such as Botox injections or facelifts that can impact facial expressions; Dental Work: Major procedures that might affect speech
- Vulnerable or protected populations (e.g. prisoners)
- Acute intoxication at the time of the assessments
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 65 év között vagy?
Helyszínek itt: Egyesült Államok
- Baylor College of MedicineHouston, Egyesült ÁllamokContact: Eric Storch, PhDToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is a large-scale pivotal clinical validation of the AI-COA® software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different subgroups.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Symptom Evaluation and Quantification for Unified Outcomes and Individualized Assessment: Pivotal Clinical Validation Phase
- Kérdések a feltételekről
- Forrás: NCT07279038: ki vehet részt
- A regiszteradat frissítve
- 2025. december 12.